Source: Intensive Care Medicine. Unidades: ICB, FM
Subjects: FISIOLOGIA, LIPÍDEOS, GORDURAS, SEPSE, GLICEMIA, ESTUDOS PROSPECTIVOS, ESTUDOS RANDOMIZADOS, LIPOPROTEÍNAS
ABNT
CAPPI, Sylas Bezerra et al. Dyslipidemia: a prospective controlled randomized trial of intensive glycemic control in sepsis. Intensive Care Medicine, v. 38, p. 634-641, 2012Tradução . . Disponível em: https://doi.org/10.1007/s00134-011-2458-z. Acesso em: 18 nov. 2024.APA
Cappi, S. B., Noritomi, D. T., Velasco, I. T., Curi, R., Loureiro, T. C. A., & Soriano, F. G. (2012). Dyslipidemia: a prospective controlled randomized trial of intensive glycemic control in sepsis. Intensive Care Medicine, 38, 634-641. doi:10.1007/s00134-011-2458-zNLM
Cappi SB, Noritomi DT, Velasco IT, Curi R, Loureiro TCA, Soriano FG. Dyslipidemia: a prospective controlled randomized trial of intensive glycemic control in sepsis [Internet]. Intensive Care Medicine. 2012 ; 38 634-641.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s00134-011-2458-zVancouver
Cappi SB, Noritomi DT, Velasco IT, Curi R, Loureiro TCA, Soriano FG. Dyslipidemia: a prospective controlled randomized trial of intensive glycemic control in sepsis [Internet]. Intensive Care Medicine. 2012 ; 38 634-641.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1007/s00134-011-2458-z